Ebola Drug From Japan May Emerge Among Key Candidates

U.S. government researchers are working hard to get an experimental flu drug from Japan’s Fujifilm Holdings Corp. quickly approved to treat Ebola, as the death toll rises in West Africa.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.